Mindray Expands Its Cardiac Biomarker Portfolio with Cutting-Edge hs-cTnI and NT-proBNP Assays, Empowering Enhanced Cardiovascular Diseases Care

Contributed by: PR Newswire

Images

PR Newswire associated0
PR Newswire associated1

Tags

Mindray-Expands

More Like This

PR Newswire associated0

Nordic Bioscience to make its precision medicine biomarker PRO-C3 available in China for research use only (RUO) in the first quarter of 2024.

PR Newswire associated0

Mindray Debuts Next-Generation BeneVision V Series Patient Monitoring System at Euroanaesthesia 2025

GlobeNewswire associated0

LumiraDx Partners with AstraZeneca & Everton in the Community to Set Up England’s First Heart & Lung Screening Hub

PR Newswire associated0

/C O R R E C T I O N -- Menarini Silicon Biosystems/

PR Newswire associated0

Menarini Silicon Biosystems announces publication of the DETECT III trial results highlighting the potential clinical utility of HER2 testing in circulating tumor cells with CELLSEARCH

Business Wire logo

Beckman Coulter and Fujirebio Expand Partnership to Develop Patient-friendly, Blood-based Neurodegenerative Disease Diagnostics

PR Newswire associated0

Nordic Bioscience launches novel Endotrophin assay

C₂N Diagnostics, LLC Announces Investment From Eisai Inc.